NCT02216266View on ClinicalTrials.gov

Evaluation if Physostigmine Reduces Symptoms in Patients Who Has Developed a Delirium in Intensive Care After a Surgery

PHASE3UnknownINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Suspected Delirium After Elective or Emergency Heart SurgeryCAM-ICU Diagnosed Delirium
Interventions
DRUG

Physostigmine

OTHER

Sodium Chloride solution

Trial Locations (1)

60590

RECRUITING

Department of Anesthesiology, Intensive-Care Medicine and Pain Therapy, Frankfurt

Sponsors

Collaborators (1)

Goethe University
All Listed Sponsors
collaborator

Goethe University

OTHER

collaborator

Dr. Franz Köhler Chemie GmbH (study medication and labeling)

UNKNOWN

lead

PD Dr. Bertram Scheller

OTHER